The post-vaccine microevolution of invasive Streptococcus pneumoniae

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Cremers, Amelieke J H ^a   Mobegi, Fredrick M ^a   De Jonge, Marien I ^a   Van Hijum, Sacha A F T ^a   Meis, Jacques F ^a,b   Hermans, Peter W M ^a,d   Ferwerda, Gerben ^a   Bentley, Stephen D ^c   Zomer, Aldert L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTERIAL GENOME; EVOLUTION; GENETICS; IMMUNOLOGY; STREPTOCOCCUS PNEUMONIAE;

BIOLOGICAL EVOLUTION; GENOME, BACTERIAL; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS PNEUMONIAE;

EID: 84945310131     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14952     Document Type: Article

References (50)

1. World Health Organization. Pneumococcal vaccines. Weekly epidemiological record 78, 110-119 (2003).
2. Pavia, M., Bianco, A., Nobile, C. G., Marinelli, P. & Angelillo, I. F. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics 123, e1103-10 (2009).
3. Bonten, M. J. et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 372, 1114-25 (2015).
4. Dagan, R. et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185, 927-36 (2002).
5. Spijkerman, J. et al. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 17, 584-91 (2011).
6. Lexau, C. A. et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294, 2043-51 (2005).
7. Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P. & George, R. C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11, 760-8 (2011).
8. Weinberger, D. M., Malley, R. & Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962-73 (2011).
9. Scott, J. R. et al. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis 205, 280-8 (2012).
10. Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM). Bacterial meningitis in the Netherlands; annual report 2013. (2014).
11. Brueggemann, A. B. et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clonespecific differences in invasive disease potential. J Infect Dis 187, 1424-32 (2003).
12. Sandgren, A. et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 189, 785-96 (2004).
13. Watson, D. A. & Musher, D. M. Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun 58, 3135-8 (1990).
14. Hanage, W. P. et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 73, 431-5 (2005).
15. Blomberg, C. et al. Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. J Infect Dis 199, 1032-42 (2009).
16. Browall, S. et al. Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children. J Infect Dis 209, 377-88 (2014).
17. Cremers, A. J., Kokmeijer, I., Groh, L., de Jonge, M. I. & Ferwerda, G. The role of ZmpC in the clinical manifestation of invasive pneumococcal disease. Int J Med Microbiol (2014).
18. Croucher, N. J. et al. Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection. PLoS Genet 9, e1003868 (2013).
19. Klugman, K. P., Bentley, S. D. & McGee, L. Determinants of invasiveness beneath the capsule of the pneumococcus. J Infect Dis 209, 321-2 (2014).
20. Lipsitch, M. et al. Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a clusterrandomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis 196, 1221-7 (2007).
21. Bogaert, D. et al. Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol 43, 74-83 (2005).
22. Gherardi, G. et al. Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine era in Italy. Antimicrob Agents Chemother 56, 4965-8 (2012).
23. Hanage, W. P. et al. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J 30, 302-8 (2011).
24. Gladstone, R. A. et al. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 33, 2015-21 (2015).
25. Chang, Q. et al. Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced. BMC Infect Dis 15, 68 (2015).
26. Croucher, N. J. et al. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 45, 656-63 (2013).
27. Van Lier, E. A. et al. Immunisation coverage National Immunisation Programme in the Netherlands. National Institute for Public Health and the Environment (2014).
28. The Dutch Working Party on Antibiotic Policy. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2012. www.swab.nl(2013).
29. Elberse, K. E. et al. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine 30, 7644-51 (2012).
30. van Deursen, A. M. et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis 18, 1729-37 (2012).
31. Cremers, A. J. et al. Effects of 7-valent pneumococcal conjugate vaccine on the severity of adult bacteremic pneumococcal pneumonia. Vaccine 32, 3989-94 (2014).
32. Watkins, E. R. et al. Vaccination drives changes in metabolic and virulence profiles of Streptococcus pneumoniae. PLoS Pathog 11, e1005034 (2015).
33. Kaatz, G. W., McAleese, F. & Seo, S. M. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 49, 1857-64 (2005).
34. Burgos, J. et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 53, 254-61 (2011).
35. Pai, R., Gertz, R. E. & Beall, B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44, 124-31 (2006).
36. Kong, F. et al. A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR. J Med Microbiol 54, 351-6 (2005).
37. Bentley, S. D. et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2, e31 (2006).
38. Zerbino, D. R. & Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18, 821-9 (2008).
39. Boetzer, M., Henkel, C. V., Jansen, H. J., Butler, D. & Pirovano, W. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27, 578-9 (2011).
40. Boetzer, M. & Pirovano, W. Toward almost closed genomes with GapFiller. Genome Biology 13, R56 (2012).
41. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068-9 (2014).
42. Enright, A. J., Van Dongen, S. & Ouzounis, C. A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 30, 1575-84 (2002).
43. Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32, 1792-7 (2004).
44. Wernersson, R. & Pedersen, A. G. RevTrans: Multiple alignment of coding DNA from aligned amino acid sequences. Nucleic Acids Res 31, 3537-9 (2003).
45. Stamatakis, A., Ludwig, T. & Meier, H. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21, 456-63 (2005).
46. Tang, J., Hanage, W. P., Fraser, C. & Corander, J. Identifying currents in the gene pool for bacterial populations using an integrative approach. PLoS Computational Biology 5, e1000455 (2009).
47. Letunic, I. & Bork, P. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res 39, W475-8 (2011).
48. Darling, A. C., Mau, B., Blattner, F. R. & Perna, N. T. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 14, 1394-403 (2004).
49. Carver, T. et al. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24, 2672-6 (2008).
50. Dutilh, B. E., Huynen, M. A., Bruno, W. J. & Snel, B. The consistent phylogenetic signal in genome trees revealed by reducing the impact of noise. Journal of Molecular Evolution 58, 527-39 (2004).